Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Influence of early neurological complications on clinical outcome following lung transplant

  • Gamez Carbonell, Josep
  • Salvadó Figueras, Maria
  • Martínez de la Ossa Vela, Alejandro
  • Deu Martín, María
  • Romero Vielva, Laura Maria
  • Román Broto, Antonio
  • Scanell Lacasa, Judith
  • Laborda Soriano, César
  • Rochera Villach, Ma Isabel
  • Nadal Clanchet, Miriam de
  • Santamarina Pérez, Estevo
  • Raguer Sanz, Nuria
  • Canela Cardona, Mercè
  • Sole Montserrat, Juan
Sistema Nerviós Autònom; Risc de malalties cardiovasculars; Procediments mèdics quirúrgics i invasius, Sistema nervioso autónomo; Riesgo de enfermedad cardiovascular; Procedimientos médicos quirúrgicos e invasivos, Autonomic Nervous System; Cardiovascular disease risk; Surgical and invasive medical procedures, Background Neurological complications after lung transplantation are common. The full spectrum of neurological complications and their impact on clinical outcomes has not been extensively studied. Methods We investigated the neurological incidence of complications, categorized according to whether they affected the central, peripheral or autonomic nervous systems, in a series of 109 patients undergoing lung transplantation at our center between January 1 2013 and December 31 2014. Results Fifty-one patients (46.8%) presented at least one neurological complication. Critical illness polyneuropathy-myopathy (31 cases) and phrenic nerve injury (26 cases) were the two most prevalent complications. These two neuromuscular complications lengthened hospital stays by a median period of 35.5 and 32.5 days respectively. However, neurological complications did not affect patients’ survival. Conclusions The real incidence of neurological complications among lung transplant recipients is probably underestimated. They usually appear in the first two months after surgery. Despite not affecting mortality, they do affect the mean length of hospital stay, and especially the time spent in the Intensive Care Unit. We found no risk factor for neurological complications except for long operating times, ischemic time and need for transfusion. It is necessary to develop programs for the prevention and early recognition of these complications, and the prevention of their precipitant and risk factors., JG is the recipient of a grant from the Spanish Fondo de Investigaciones Sanitarias (FIS PI13-01272-FEDER).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of early neurological complications on clinical outcome following lung transplant

  • Gamez, Josep|||0000-0003-3127-7486
  • Salvado, Maria|||0000-0002-1526-1903
  • Martinez-de La Ossa, Alejandro
  • Deu, Maria
  • Romero, Laura
  • Roman, Antonio
  • Sacanell, Judith
  • Laborda, César
  • Rochera, Isabel
  • Nadal Clanchet, Miriam de|||0000-0002-4559-2463
  • Carmona Jiménez, Francesc|||0000-0001-6474-9860
  • Santamarina Perez, Estevo|||0000-0003-1915-0335
  • Raguer, Nuria|||0000-0002-9471-9096
  • Canela, Mercedes
  • Solé, Joan
Neurological complications after lung transplantation are common. The full spectrum of neurological complications and their impact on clinical outcomes has not been extensively studied. We investigated the neurological incidence of complications, categorized according to whether they affected the central, peripheral or autonomic nervous systems, in a series of 109 patients undergoing lung transplantation at our center between January 1 2013 and December 31 2014. Fifty-one patients (46.8%) presented at least one neurological complication. Critical illness polyneuropathy-myopathy (31 cases) and phrenic nerve injury (26 cases) were the two most prevalent complications. These two neuromuscular complications lengthened hospital stays by a median period of 35.5 and 32.5 days respectively. However, neurological complications did not affect patients' survival. The real incidence of neurological complications among lung transplant recipients is probably underestimated. They usually appear in the first two months after surgery. Despite not affecting mortality, they do affect the mean length of hospital stay, and especially the time spent in the Intensive Care Unit. We found no risk factor for neurological complications except for long operating times, ischemic time and need for transfusion. It is necessary to develop programs for the prevention and early recognition of these complications, and the prevention of their precipitant and risk factors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

  • Lopez-Lopez, Alan
  • Gamez, Josep|||0000-0003-3127-7486
  • Syriani, Emilio
  • Morales, Miguel
  • Salvado, Maria|||0000-0002-1526-1903
  • Rodríguez, Manuel J.
  • Mahy, Nicole
  • Vidal-Taboada, Jose M.
The objective of this study was to investigate the association of functional variants of the human CX3CR1 gene (Fractalkine receptor) with the risk of Amyotrophic Lateral Sclerosis (ALS), the survival and the progression rate of the disease symptoms in a Spanish ALS cohort. 187 ALS patients (142 sporadic [sALS] and 45 familial) and 378 controls were recruited. We investigated CX3CR1 V249I (rs3732379) and T280M (rs3732378) genotypes and their haplotypes as predictors of survival, the progression rate of the symptoms (as measured by ALSFRS-R and FVC decline) and the risk of suffering ALS disease. The results indicated that sALS patients with CX3CR1 249 I/I or 249 V/I genotypes presented a shorter survival time (42.27±4.90) than patients with 249 V/V genotype (67.65±7.42; diff -25.49 months 95%CI [-42.79,-8.18]; p = 0.004; adj-p = 0.018). The survival time was shorter in sALS patients with spinal topography and CX3CR1 249 I alleles (diff = -29.78 months; 95%CI [-49.42,-10.14]; p = 0.003). The same effects were also observed in the spinal sALS patients with 249 I -280 M haplotype (diff = -27.02 months; 95%CI [-49.57, -4.48]; p = 0.019). In the sALS group, the CX3CR1 249 I variant was associated with a faster progression of the disease symptoms (OR = 2.58; 95IC% [1.32, 5.07]; p = 0.006; adj-p = 0.027). There was no evidence for association of these two CX3CR1 variants with ALS disease risk. The association evidenced herein is clinically relevant and indicates that CX3CR1 could be a disease-modifying gene in sALS. The progression rate of the disease's symptoms and the survival time is affected in patients with one or two copies of the CX3CR1 249I allele. The CX3CR1 is the most potent ALS survival genetic factor reported to date. These results reinforce the role of the immune system in ALS pathogenesis.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Influence of early neurological complications on clinical outcome following lung transplant

  • Gamez Carbonell, Josep
  • Salvadó Figueras, Maria
  • Martínez de la Ossa Vela, Alejandro
  • Deu Martín, María
  • Romero Vielva, Laura Maria
  • Román Broto, Antonio
  • Scanell Lacasa, Judith
  • Laborda Soriano, César
  • Rochera Villach, Ma Isabel
  • Nadal Clanchet, Miriam de
  • Santamarina Pérez, Estevo
  • Raguer Sanz, Nuria
  • Canela Cardona, Mercè
  • Sole Montserrat, Juan
Sistema Nerviós Autònom; Risc de malalties cardiovasculars; Procediments mèdics quirúrgics i invasius, Sistema nervioso autónomo; Riesgo de enfermedad cardiovascular; Procedimientos médicos quirúrgicos e invasivos, Autonomic Nervous System; Cardiovascular disease risk; Surgical and invasive medical procedures, Background Neurological complications after lung transplantation are common. The full spectrum of neurological complications and their impact on clinical outcomes has not been extensively studied. Methods We investigated the neurological incidence of complications, categorized according to whether they affected the central, peripheral or autonomic nervous systems, in a series of 109 patients undergoing lung transplantation at our center between January 1 2013 and December 31 2014. Results Fifty-one patients (46.8%) presented at least one neurological complication. Critical illness polyneuropathy-myopathy (31 cases) and phrenic nerve injury (26 cases) were the two most prevalent complications. These two neuromuscular complications lengthened hospital stays by a median period of 35.5 and 32.5 days respectively. However, neurological complications did not affect patients’ survival. Conclusions The real incidence of neurological complications among lung transplant recipients is probably underestimated. They usually appear in the first two months after surgery. Despite not affecting mortality, they do affect the mean length of hospital stay, and especially the time spent in the Intensive Care Unit. We found no risk factor for neurological complications except for long operating times, ischemic time and need for transfusion. It is necessary to develop programs for the prevention and early recognition of these complications, and the prevention of their precipitant and risk factors., JG is the recipient of a grant from the Spanish Fondo de Investigaciones Sanitarias (FIS PI13-01272-FEDER).